Longkou Union Chemical Co., Ltd.
SZSE:301209.SZ
24.3 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 128.285 | 128.594 | 120.059 | 112.162 | 94.154 | 102.012 | 102.621 | 114.275 | 155.272 | 169.816 | 159.827 | 127.579 | 132.267 | 132.267 | 140.279 |
| Cost of Revenue
| 102.464 | 105.58 | 98.467 | 95.835 | 80.035 | 87.275 | 86.163 | 98.938 | 127.871 | 135.388 | 125.972 | -207.862 | 103.968 | 103.968 | 0 |
| Gross Profit
| 25.821 | 23.014 | 21.592 | 16.327 | 14.119 | 14.737 | 16.458 | 15.337 | 27.4 | 34.428 | 33.854 | 335.441 | 28.3 | 28.3 | 140.279 |
| Gross Profit Ratio
| 0.201 | 0.179 | 0.18 | 0.146 | 0.15 | 0.144 | 0.16 | 0.134 | 0.176 | 0.203 | 0.212 | 2.629 | 0.214 | 0.214 | 1 |
| Reseach & Development Expenses
| 6.168 | 5.67 | 5.248 | 4.989 | 4.58 | 4.222 | 6.204 | 3.984 | 6.411 | 5.214 | 7.7 | 4.787 | 4.611 | 4.611 | 0 |
| General & Administrative Expenses
| 0.543 | 2.733 | -2.632 | 6.178 | 0.643 | 1.816 | -2.255 | 11.199 | -3.092 | 1.916 | 2.611 | 2.664 | 2.284 | 2.284 | 0 |
| Selling & Marketing Expenses
| 1.685 | 1.268 | 1.399 | 1.759 | 1.092 | 0.484 | 1.235 | 1.127 | 1.2 | 1.119 | 1.265 | 0.735 | 0.798 | 0.798 | 0 |
| SG&A
| 4.856 | 4.426 | -1.233 | 7.937 | 1.735 | 2.299 | -1.02 | 12.326 | -1.892 | 3.036 | 5.573 | 3.062 | 3.455 | 3.455 | 0 |
| Other Expenses
| -0.731 | 0.06 | -0.076 | -0.114 | -0.367 | -0.171 | -0.386 | 4.779 | -4.772 | -0.153 | 0 | 0 | 0 | 0 | -400.053 |
| Operating Expenses
| 11.755 | 10.035 | 11.082 | 10.127 | 9.647 | 4.937 | 4.762 | 10.84 | 9.438 | 8.205 | 14.13 | 7.636 | 8.042 | 8.042 | -400.053 |
| Operating Income
| 14.066 | 12.979 | 11.606 | 7.052 | 9.009 | 10.728 | 12.757 | 9.291 | 24.114 | 25.22 | -312.46 | 349.318 | 20.989 | 20.989 | -259.774 |
| Operating Income Ratio
| 0.11 | 0.101 | 0.097 | 0.063 | 0.096 | 0.105 | 0.124 | 0.081 | 0.155 | 0.149 | -1.955 | 2.738 | 0.159 | 0.159 | -1.852 |
| Total Other Income Expenses Net
| 1.212 | 3.35 | -2.566 | -0.114 | -0.367 | -0.171 | -0.386 | 0 | 0.008 | -0.153 | 332.321 | -334.324 | -0.568 | -0.568 | 274.247 |
| Income Before Tax
| 15.277 | 16.329 | 11.529 | 6.939 | 8.642 | 10.557 | 12.372 | 9.292 | 24.122 | 25.068 | 19.861 | 14.994 | 20.421 | 20.421 | 14.473 |
| Income Before Tax Ratio
| 0.119 | 0.127 | 0.096 | 0.062 | 0.092 | 0.103 | 0.121 | 0.081 | 0.155 | 0.148 | 0.124 | 0.118 | 0.154 | 0.154 | 0.103 |
| Income Tax Expense
| 1.545 | 2.306 | 1.82 | 0.332 | 0.669 | 1.017 | 0.077 | -0.996 | 4.563 | 3.054 | -0.212 | 2.271 | 3.212 | 3.212 | 0.329 |
| Net Income
| 13.732 | 14.023 | 9.709 | 6.607 | 7.974 | 9.54 | 12.295 | 10.288 | 19.559 | 22.014 | 20.073 | 12.722 | 17.209 | 17.209 | 14.144 |
| Net Income Ratio
| 0.107 | 0.109 | 0.081 | 0.059 | 0.085 | 0.094 | 0.12 | 0.09 | 0.126 | 0.13 | 0.126 | 0.1 | 0.13 | 0.13 | 0.101 |
| EPS
| 0.17 | 0.18 | 0.12 | 0.083 | 0.1 | 0.12 | 0.15 | 0.13 | 0.24 | 0.37 | 0.33 | 0.21 | 0.28 | 0.29 | 0 |
| EPS Diluted
| 0.17 | 0.18 | 0.12 | 0.083 | 0.1 | 0.12 | 0.15 | 0.13 | 0.24 | 0.37 | 0.33 | 0.21 | 0.28 | 0.29 | 0 |
| EBITDA
| 17.875 | 14.584 | 11.54 | 7.301 | 3.724 | 9.643 | 11.521 | 3.306 | 16.811 | 27.004 | -312.46 | 349.318 | 24.364 | 24.364 | -259.774 |
| EBITDA Ratio
| 0.139 | 0.113 | 0.096 | 0.065 | 0.04 | 0.095 | 0.112 | 0.029 | 0.108 | 0.159 | -1.955 | 2.738 | 0.184 | 0.184 | -1.852 |